mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |